Atea Share Price
NASDAQ: AVIR | Small Cap | HealthcareAtea Stock Performance
Atea Share Price Today
As of 21 November 2026, Atea Pharmaceuticals, Inc.'s share price is $3.98. The stock opened at $3.90, compared to its previous close of $3.92. During today's trading session, Atea Pharmaceuticals, Inc.'s share price traded between $3.90 and $4.08, with an average price of $3.99. Over the past 52 weeks, the stock has recorded a high of $6.43 and a low of $2.93. In terms of performance, Atea Pharmaceuticals, Inc.'s share price has declined by 14.50% over the last six months and is up 28.80% on a year-on-year basis.
Atea Share Price Chart
Atea Quarterly Profit & Loss
All figures in USD
Atea Annual Profit & Loss
All figures in USD
Atea Balance Sheet
All figures in USD Million
Atea Cash Flow
All figures in USD Million
About Atea
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Atea Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $4.23 | $3.96 | -3.27% |
Oct 2026 | $5.11 | $4.09 | -21.42% |
Sep 2026 | $5.38 | $5.21 | -4.40% |
Aug 2026 | $4.70 | $5.45 | +16.08% |
Jul 2026 | $4.69 | $4.70 | +0.97% |
Jun 2026 | $4.55 | $4.65 | -0.11% |
May 2026 | $5.41 | $4.66 | -15.59% |
Apr 2026 | $5.43 | $5.51 | +2.60% |
Mar 2026 | $4.71 | $5.38 | +14.61% |
Feb 2026 | $4.18 | $4.69 | +10.61% |
Jan 2026 | $3.52 | $4.24 | +18.27% |
Dec 2025 | $3.05 | $3.58 | +16.02% |